Ventricular septal defect

Intracardiac Echocardiography Devices Market size to grow by USD 11.5 billion from 2022 to 2030; Increasing number of heart-related medical conditions and treatments to boost the market growth - Facts & Factor

Retrieved on: 
Wednesday, June 28, 2023
Heart, Ventricular septal defect, Mayo Clinic, Left atrial appendage occlusion, Life, ICE, Catheter, Hospital, Philips, Patient, Investment, Electrophysiology, TEE, Universal health care, UHC, Growth, Clinical professor, Medical imaging, Health care

Global Intracardiac Echocardiography Devices Market: Growth Drivers

Key Points: 
  • Global Intracardiac Echocardiography Devices Market: Growth Drivers
    Increasing number of heart-related medical conditions and treatments to propel market growth.
  • The global intracardiac echocardiography devices market is projected to grow owing to the increasing number of patients suffering from heart-related conditions and their subsequent treatment.
  • Most traditional tools like transoesophageal echocardiography (TEE) are used to prepare for and act as guiding tools during interventional treatment.
  • Global Intracardiac Echocardiography Devices Market: Segmentation
    The global intracardiac echocardiography devices market is segmented based on end-user, application, and region.

Dr. Joseph Forbess Joins Nicklaus Children's as Chief of Cardiovascular Surgery

Retrieved on: 
Wednesday, June 28, 2023
Duke University Hospital, Boston Children's Hospital, Ventricular septal defect, University, CV, University of Maryland Medical System, Isenberg School of Management, American Heart Association, Society of Thoracic Surgeons, American College of Cardiology, English, University of Texas at Austin, Research, American College of Surgeons, University of Maryland Medical Center, U.S. News & World Report, University of Maryland School of Medicine, Harvard Medical School, Cardiothoracic surgery, University of Ottawa Heart Institute, Maryland School, Hospital, Patient, NCPS, Child, Pediatrics, Society, General surgery, Growth, American College, Trauma, Elective surgery, News, Nursing, Dentistry, Nicklaus Children's Hospital, Cardiology

MIAMI, June 28, 2023 /PRNewswire/ -- Renowned pediatric cardiovascular surgeon Dr. Joseph M. Forbess has joined Nicklaus Children's Pediatric Specialists (NCPS) as chief of the Section of Cardiovascular (CV) Surgery, and assumes a leadership position within the Nicklaus Children's Heart Institute.

Key Points: 
  • MIAMI, June 28, 2023 /PRNewswire/ -- Renowned pediatric cardiovascular surgeon Dr. Joseph M. Forbess has joined Nicklaus Children's Pediatric Specialists (NCPS) as chief of the Section of Cardiovascular (CV) Surgery, and assumes a leadership position within the Nicklaus Children's Heart Institute.
  • Dr. Forbess will lead the Nicklaus Children's Heart Institute in collaboration with Dr. Lourdes Prieto, chief of the Section of Cardiology, with support from Dr. Burke.
  • Nicklaus Children's is ranked among the nation's best hospitals for pediatric cardiology and heart surgery by U.S. News & World Report.
  • Dr. Burke has been an instrumental leader in Nicklaus Children's Cardiovascular Surgery program, having helped the team and the program attain national notoriety.

Hassenfeld Children's Hospital at NYU Langone is No. 1 in New York for Pediatric Cardiology & Heart Surgery

Retrieved on: 
Tuesday, June 27, 2023
Survival rate, Congenital Heart Surgeons' Society, Heart, Society, Partnership, CHSD, Ventricular septal defect, Hospital, NYU, Hope, Birth defect, MBA, Children's Hospital, Annals of Pediatric Cardiology, U.S. News & World Report, Transplant, Cardiothoracic surgery, MD, Patient, Division, Nursing, Risk, Cardiology, Hassenfeld Children's Hospital, NYU Langone Health, Faculty, Gabriel Andral, PAT, Social work, News, Anesthesiology, Dentistry, Pediatrics

NEW YORK, June 27, 2023 /PRNewswire/ -- Hassenfeld Children's Hospital at NYU Langone is the highest ranked in New York for pediatric cardiology and heart surgery care, based on the national specialty ranking in the 2023-2024 U.S. News & World Report's "Best Children's Hospitals" guide released this week.

Key Points: 
  • NEW YORK, June 27, 2023 /PRNewswire/ -- Hassenfeld Children's Hospital at NYU Langone is the highest ranked in New York for pediatric cardiology and heart surgery care, based on the national specialty ranking in the 2023-2024 U.S. News & World Report's "Best Children's Hospitals" guide released this week.
  • "We are immensely proud to be recognized, validating our commitment to deliver high-quality, family-centered care to those who need us most."
  • "These successful outcomes are why Hassenfeld Children's Hospital is a recognized leader in the multidisciplinary care of pediatric heart conditions."
  • Congenital heart surgery at Hassenfeld Children's Hospital is a national leader performing nearly 250 operations annually on the full spectrum of pediatric and adult congenital heart disease including transplantation.

Does Congenital Heart Disease Cause Arrhythmias? Memorial Cardiac and Vascular Institute Has the 4-1-1

Retrieved on: 
Tuesday, June 27, 2023
Heart, Arrhythmia, Ventricular septal defect, Atrial flutter, DOES, Palpitations, Intra, Stroke, HOW, Atrial fibrillation, Movement, MD, Risk, Heart rate, Health, Fatigue, Dentistry, Coal, Liquor, Ventricular fibrillation

HOLLYWOOD, Fla., June 27, 2023 /PRNewswire-PRWeb/ -- Taking care of your health is always important, especially when you're born with a heart defect (congenital heart disease). Having a heart defect makes other health problems more likely. Arrhythmia, an irregular heartbeat, is a serious concern for those with adult congenital heart disease (ACHD).

Key Points: 
  • HOLLYWOOD, Fla., June 27, 2023 /PRNewswire-PRWeb/ -- Taking care of your health is always important, especially when you're born with a heart defect (congenital heart disease).
  • Arrhythmia, an irregular heartbeat, is a serious concern for those with adult congenital heart disease (ACHD).
  • Most arrhythmias aren't fatal, but they can cause symptoms like heart palpitations, a rapid heart rate and fatigue.
  • HOW DOES CONGENITAL HEART DISEASE CAUSE ARRHYTHMIA?

Texas Children's Hospital Remains No. 1 Pediatric Hospital in the State of Texas for 15th Consecutive Year

Retrieved on: 
Wednesday, June 21, 2023
Exercise, News, Heart, Ventricular septal defect, Congenital Heart Surgeons' Society, Hospital, Philippine Heart Center, ACH, U.S. News & World Report, Texas Children's Hospital, Patient, Patient safety, Diagnosis, Health, Annual report, Lester, Canadian Screen Award for Best Children's or Youth Non-Fiction Program or Series, Nursing, Dentistry

HOUSTON, June 21, 2023 /PRNewswire/ -- Texas Children's Hospital is proud and honored once again to be named a leader in pediatric health care by U.S. News & World Report, ranking No. 1 in Texas and No. 3 nationally in its 2023-2024 Best Children's Hospitals report.

Key Points: 
  • In December 2020, Texas Children's opened a first-of-its-kind dedicated floor designed by and for patients with adult congenital heart (ACH) disease.
  • Texas Children's ACH Program is accredited by the Adult Congenital Heart Association and is one of only four accredited programs in Texas.
  • In 2021, only 89 children's hospitals were ranked in at least one of the 10 pediatric specialties evaluated for this annual report.
  • Ten hospitals, including Texas Children's Hospital, ranked at the top of their class and were named to the 2022-2023 Honor Roll .

FDA Approves Innovative 4D Flow MRI Blood Flow Analysis Software from Cardio Flow Design Inc. (Japan) - Enhance Cardiovascular Diagnostic Accuracy

Retrieved on: 
Monday, June 19, 2023
Technology, Surgery, Medical Devices, FDA, Cardiology, Software, Biotechnology, Radiology, Health, Heart, US Foods, Ventricular septal defect, Pediatrics, Doctor of Philosophy, Anatomy, 3D, Multimedia, Research, Child, Associate, 2D, Blood, Liaquat National Hospital, MRI, Children's National Hospital, MD, Patient, Physician, Algorithm, Diagnosis, Vector field, Food, Safety, Medical device, Medical imaging

The FDA approval is significant as it recognizes the safety and effectiveness of iTFlow® in analyzing blood flow through 4D Flow MRI data, with the potential to enhance diagnostic accuracy for patients with cardiovascular diseases and heart conditions.

Key Points: 
  • The FDA approval is significant as it recognizes the safety and effectiveness of iTFlow® in analyzing blood flow through 4D Flow MRI data, with the potential to enhance diagnostic accuracy for patients with cardiovascular diseases and heart conditions.
  • iTFlow® is an innovative software solution developed by Cardio Flow Design Inc. that supports blood flow analysis and evaluation in the fields of cardiovascular surgery and radiology.
  • Based on MRI data, users can perform their own analysis and visualization of blood flow.
  • We have been pursuing the concept of blood flow analysis with 4D flow MRI for many years, and iTFlow® encapsulates the essence of this concept.

PECA Labs Achieves Successful First-In-Human Implant of the MASA Valve Pediatric Pulmonary Valved Conduit in U.S. Clinical Trial

Retrieved on: 
Tuesday, June 13, 2023
Health, Medical Devices, Hospitals, Clinical Trials, Research, Science, Cardiology, Investigation of diving accidents, Failure, CHOP, Calcification, Pediatrics, Anatomy, Ventricular septal defect, University of Ottawa Heart Institute, HUD, Gold, Patient, Risk, Child, Rooting (Android), Disease, Pulmonary valve, Mortality, IDE, Cincinnati, Hospital, FDA, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Food, Medical imaging, PECA

Designed for pediatrics, the MASA Valve is a polymeric valved conduit for pulmonary valve reconstruction.

Key Points: 
  • Designed for pediatrics, the MASA Valve is a polymeric valved conduit for pulmonary valve reconstruction.
  • The company has begun enrollment for the study at four clinical sites in the U.S. as part of its MASA Valve Early Feasibility Clinical Study (MVEFS).
  • Children’s Hospital of Philadelphia (CHOP), a world-renowned children’s hospital and research institute, became the first site in the world to implant a MASA Valve in a pediatric patient.
  • This marks a significant milestone in PECA Labs’ mission to bring the first polymeric pulmonary valve to market and improve outcomes for patients.

Starlight Cardiovascular Appoints Paul G. Yock, MD to its Board of Directors

Retrieved on: 
Tuesday, June 13, 2023
Rapid Exchange of Information System, Ventricular septal defect, Technology education, The Biodesign Institute, Stanford University, University of Washington Department of Bioengineering, IVUS, Congenital heart defect, National academy, Stanford University School of Medicine, Standard of care, SAN, Birth defect, Biological engineering, National Academy of Engineering of Korea, Entrepreneurship, CHD, Pharmaceutical industry, Engineering, Medicine

SAN DIEGO, June 13, 2023 /PRNewswire/ -- Paul G. Yock has joined the Starlight Cardiovascular Board of Directors. Dr. Yock is the Founder, Director Emeritus, and a Board Member of the Stanford Byers Center for Biodesign. He is the former Martha Meier Weiland Professor of Medicine, founding co-chair of Stanford University's Department of Bioengineering, and the 2018 recipient of the National Academy of Engineering's Gordon Prize for Innovation in Engineering and Technology Education. Yock, who is trained as an interventional cardiologist, is known for his numerous innovative contributions to medical technology, including the Rapid Exchange angioplasty and stenting system, intravascular ultrasound (IVUS), and the Smart Needle.

Key Points: 
  • SAN DIEGO, June 13, 2023 /PRNewswire/ -- Paul G. Yock has joined the Starlight Cardiovascular Board of Directors.
  • "We are overjoyed that Paul has joined the Starlight family," stated Beverly Tang, co-Founder and CEO of Starlight Cardiovascular.
  • Yock was appointed as an independent director and joins Alf Grunwald, Tom Duerig, and Beverly Tang on the Board of Directors.
  • "Starlight Cardiovascular is taking on this challenge by developing highly novel pediatric technologies -- and, equally important, pioneering novel approaches to business execution.

Nu Skin Celebrates 20th Annual Force for Good Day with Global Day of Service

Retrieved on: 
Wednesday, June 7, 2023
Good, Heart, Food, Ventricular septal defect, Education, Refugee, Skin, Convoy, Intermountain, Hospital, Patient, Earthquake, Restaurant, Primary, Book, Nursing, Health insurance, Pharmaceutical industry

PROVO, Utah, June 07, 2023 (GLOBE NEWSWIRE) -- Today, Nu Skin is hosting its 20th annual Force for Good Day to support its global humanitarian efforts.

Key Points: 
  • PROVO, Utah, June 07, 2023 (GLOBE NEWSWIRE) -- Today, Nu Skin is hosting its 20th annual Force for Good Day to support its global humanitarian efforts.
  • To celebrate the company’s founding and to give back to local communities, each Nu Skin region sets aside a day to participate in service projects as part of the company mission to be a global force for good.
  • At the Nu Skin global headquarters in Utah, this year's Force for Good Day is focused on extending kindness and support to children battling illnesses in hospitals or undergoing surgery.
  • More than 900 Nu Skin employees and their families will participate in a day of service to benefit 1,000 hospitalized children around the world.

Global Cerebral Oximetry Monitoring Market to 2030: Increasing Incidence of Critical Heart Illness Drives Growth - ResearchAndMarkets.com

Retrieved on: 
Monday, June 5, 2023
Health, Medical Devices, Cardiology, Patient, Partnership, Ventricular septal defect, Prevalence, Bed, COVID-19, Brain damage, Journal of Cardiothoracic Surgery, Chapter Three, Ventilation, CDC, Incidence, Hospital, Journal, Physician, Risk, Korea Disease Control and Prevention Agency, Observation, CCHD, Growth, Mortality, Infant, Diagnosis, Notifiable disease, CHD, Pharmaceutical industry, ICU

The key factors driving the growth of the market are the increasing incidence of critical heart illness.

Key Points: 
  • The key factors driving the growth of the market are the increasing incidence of critical heart illness.
  • Still, several research studies showed that this traditional method could be unreliable and fail to detect new infants with CCHD.
  • The COVID-19 pandemic negatively affected the global cerebral oximetry monitoring market due to decreased outpatient visits and a dramatic reduction in essential and non-essential surgeries.
  • The growing prevalence of non-communicable diseases and rising developments in cerebral oximetry devices are the key factors driving market growth in the region
    Chapter 3.